Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503519 | SCV000594310 | uncertain significance | not specified | 2015-11-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000648787 | SCV000770608 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2P; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 | 2023-03-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DAG1 protein function. ClinVar contains an entry for this variant (Variation ID: 434895). This variant has not been reported in the literature in individuals affected with DAG1-related conditions. This variant is present in population databases (rs368597067, gnomAD 0.03%). This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 811 of the DAG1 protein (p.Pro811Ser). |
Revvity Omics, |
RCV003144295 | SCV003834246 | uncertain significance | not provided | 2021-06-17 | criteria provided, single submitter | clinical testing |